EBM BLS: Tirzepatide Leads to Resolution of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Without Worsening of Fibrosis.
Saved in:
| Title: | EBM BLS: Tirzepatide Leads to Resolution of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Without Worsening of Fibrosis. |
|---|---|
| Authors: | Campbell LA; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA., Fuest S; Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Jackson CD; Department of Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA. christopherjackson@usf.edu. |
| Source: | Journal of general internal medicine [J Gen Intern Med] 2026 Apr; Vol. 41 (5), pp. 1467-1469. Date of Electronic Publication: 2026 Jan 15. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8605834 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1497 (Electronic) Linking ISSN: 08848734 NLM ISO Abbreviation: J Gen Intern Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1525-1497 |
|---|---|
| DOI: | 10.1007/s11606-025-10123-6 |
